tiprankstipranks
SynAct Pharma AB (SE:SYNACT)
:SYNACT
Sweden Market
SYNACT
SynAct Pharma AB
RESEARCH TOOLSreports
Want to see SE:SYNACT full AI Analyst Report?

SynAct Pharma AB (SYNACT) Stock News & Sentiment

2 Followers
SynAct Pharma Updates Nomination Committee Ahead of 2026 AGM
Premium
Company Announcements
SynAct Pharma Updates Nomination Committee Ahead of 2026 AGM
8d ago
SynAct Pharma Publishes 2025 Annual Report on Inflammatory Disease Pipeline
Premium
Company Announcements
SynAct Pharma Publishes 2025 Annual Report on Inflammatory Disease Pipeline
16d ago
SynAct Pharma Raises Share Capital Through Directed Issue
Premium
Company Announcements
SynAct Pharma Raises Share Capital Through Directed Issue
1M ago
SynAct Pharma Starts Phase 2 Dengue Trial of Resomelagon in Brazil
Premium
Company Announcements
SynAct Pharma Starts Phase 2 Dengue Trial of Resomelagon in Brazil
1M ago
SynAct Pharma Targets RA Partnerships With BIO-Europe Spring 2026 Showcase
Premium
Company Announcements
SynAct Pharma Targets RA Partnerships With BIO-Europe Spring 2026 Showcase
1M ago
SynAct Pharma Sets Capital Markets Day as It Enters Key Clinical Inflection Point
Premium
Company Announcements
SynAct Pharma Sets Capital Markets Day as It Enters Key Clinical Inflection Point
2M ago
SynAct Pharma Raises SEK 51.9 Million in Directed Share Issue to Strengthen Runway and Deal Leverage
Premium
Company Announcements
SynAct Pharma Raises SEK 51.9 Million in Directed Share Issue to Strengthen Runway and Deal Leverage
2M ago
More SE:SYNACT News >

SYNACT News on the Web

SynAct Pharma Publishes 2025 Annual Report on Inflammatory Disease Pipeline
TipRanks News
Bullish
SynAct Pharma Sets Capital Markets Day as It Enters Key Clinical Inflection Point
TipRanks News
Bullish
SynAct Pharma Plans Capital Markets Day Ahead of Key Clinical Readouts
TipRanks News
Bullish
SynAct Pharma Hits Recruitment Milestone in Phase 2b Rheumatoid Arthritis Trial
TipRanks News
Bullish
SynAct Pharma Launches Phase 2 RESPIRE Trial of Resomelagon in Viral Respiratory Insufficiency
TipRanks News
Bullish
SynAct Pharma Launches Share Buyback to Optimize Capital Structure
TipRanks News
Bullish
SynAct Pharma Secures SEK 17.7 Million from Warrant Conversion
TipRanks News
Neutral
SynAct Pharma AB Announces Increase in Shares and Votes
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
SE:SYNACT
Sector Average
Media Buzz
This Week1 articles
Weekly Average1 articles
News Sentiment
This Week100%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is SE:SYNACT’s Media Buzz Sentiment?
1 articles about SE:SYNACT were published this week. In an average week, 1 articles are published.
    What is SE:SYNACT’s weekly average amount of articles?
    In an average week, 1 articles about SE:SYNACT are published.
      What is SE:SYNACT’s News Sentiment?
      100% of articles about SE:SYNACT were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        TVTXTravere Therapeutics
        HVOOpen Orphan Plc
        PBMPsyence Biomedical
        QDELQuidelOrtho
        Showing the stocks with the most bullish news sentiment over the past week